TRXC TransEnterix Inc New

SafeStitch Medical, Inc. (OTCBB:SFES) (the �Company� or �SafeStitch�) announced today that senior management will present at the UBS 2008 Global Life Sciences Conference on Monday, September 22, 2008 at 4:00 PM EDT. The conference will be held at the Grand Hyatt New York in New York City, and SafeStitch senior management will provide a review of recent corporate developments. The audio portion of the company�s presentation will be webcast live through the UBS website. To access the audio webcast, go to www.ibb.ubs.com and click on the "Conferences" icon in the center right of the page. Follow the link for Webcast next to the�"Global�Life Sciences"�Conference heading. An archived version of the webcast will also be available beginning at 7:00 PM EDT, and will remain available until October 25th. SafeStitch Medical, Inc. is a medical device company developing endoscopic and minimally invasive surgical devices. The Company is headquartered in Miami, Florida, and also has a research and development office in Omaha, Nebraska. SafeStitch�s product portfolio includes a gastroplasty device for endoscopic bariatric surgery (obesity surgery) and endoscopic repair of gastroesophageal reflux disorder (GERD), as well as an endoscopic device for excision and diagnosis of Barrett's esophagus. The Company also plans to market a standard bite block, as well as the first airway bite block, to be used during endoscopy, and is pioneering the Smart Dilator for esophageal strictures. SafeStitch is also developing products for hernia repair and natural orifice transluminal endoscopic surgery (NOTES). Information about the Company may be found on its website at www.safestitch.com.